- Home
- USEA vs NVNO Comparison
USEA vs NVNO Comparison
Compare USEA & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | USEA | NVNO |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2M | 16.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | USEA | NVNO |
|---|---|---|
| Price | $1.78 | $0.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 86.9K | ★ 433.9K |
| Earning Date | 11-11-2025 | 10-31-2025 |
| Dividend Yield | ★ 7.65% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $42,025,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.00 | $0.30 |
| 52 Week High | $2.22 | $5.62 |
Technical Indicators
Market Signals| Indicator | USEA | NVNO |
|---|---|---|
| Relative Strength Index (RSI) | 47.80 | 45.06 |
| Support Level | $1.64 | $0.31 |
| Resistance Level | $2.22 | $0.37 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 24.48 | 69.79 |
Price Performance
Historical ComparisonAbout USEA United Maritime Corporation
United Maritime Corp is an international shipping company. It is engaged in seaborne transportation services. The group currently operates a fleet of five dry bulk vessels, comprising two Kamsarmax and three Panamax vessels with an aggregate cargo-carrying capacity of approximately 396,297 dwt.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.